Healthcare - Biotechnology - NASDAQ - US
$ 1.21
-3.97 %
$ 20.4 M
Market Cap
-0.95
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
28.73%
Net Income
Estimate
23.60%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Unity Biotechnology, Inc.
UBX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart UBX
EBIT FORECAST
EBIT Forecast Chart UBX
NET INCOME FORECAST
Net Income Chart UBX